PiezoGel
Financiado
Novel piezoelectirc peptide based scaffold for 3D cell culture
Tissue regeneration has emerged as a promising novel therapy for various disease conditions. A key requirement for the implementation of this advanced approach is the efficient, reliable and reproducible growth of 3D cell cultures...
Tissue regeneration has emerged as a promising novel therapy for various disease conditions. A key requirement for the implementation of this advanced approach is the efficient, reliable and reproducible growth of 3D cell cultures, including organoid structures. State-of-the-art 3D culture media support the growth of such cultures, yet exhibit several key setbacks, including low reproducibility and limited modularity. Moreover, no commercial piezoelectric media are currently available, thus prohibiting the option of inducing electrical stimulation of the cells via mechanical stimuli, similar to the in vivo function of several tissues. Here, we aim to develop PiezoGel, a biocompatible, reproducible, controllable and piezoelectric medium for 3D cell cultures. The newly-designed medium will be based on two components, a cell-supporting hydrogel and a piezoelectric self-assembled peptide structure. In the scope of the BISON-694426 Advanced ERC project, we identified promising molecular building blocks for each of these components. The Proof of Concept project will focus both on technological development of the PiezoGel matrix and on business feasibility. Thus, the formulation of the newly-designed cell medium will be optimized, and the resulting matrix will be examined for various properties, including mechanical rigidity and piezoelectricity. The growth of diverse organoid cultures, as well as stem cell differentiation, will be further tested and calibrated. Relevant stakeholders will be approached allowing to map the product requirements and expected features directly from the users. In parallel, the regulatory compliance of the PiezoGel medium will be verified, and the relevant material and methodologies will be patented. We envision diverse applications for the PiezoGel technology, including establishing 3D cell cultures as drug development platforms, basic research exploration, and further advancement of the tissue regeneration field.
ver más
Duración del proyecto: 20 meses
Fecha Inicio: 2021-03-25
Fecha Fin: 2022-11-30
Fecha Fin: 2022-11-30
Línea de financiación: concedida
El organismo H2020 notifico la concesión del proyecto el día 2022-11-30
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
ERC-2020-POC:
Call for proposals for ERC Proof of Concept Grant
Cerrada
hace 4 años
Presupuesto
El presupuesto total del proyecto asciende a
150K€
Líder del proyecto
TEL AVIV UNIVERSITY
No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico
TRL
4-5
Perfil tecnológico
TRL
4-5
180.23K€ |
Participante